Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

Blood (2021) 138 (7): 507–519.

https://doi.org/10.1182/blood.2021011103

Published: 2021

Includes: Supplemental data

Journal Articles

Knowledge Transfer between Artificial Neural Networks for Different Multicolor Flow Cytometry Protocols Improves Classification Performance for Rare B-Cell Neoplasm Subtypes

Nanditha Mallesh, Max Zhao, Franz Elsner, PhD, Hannes Lueling, PhD, Richard Schabath, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD, Peter Krawitz, MD, Wolfgang Kern, MD

Blood (2019) 134 (Supplement_1): 2094.

https://doi.org/10.1182/blood-2019-130483

Published: 2019

Journal Articles

Management of CAR T-Cell Toxicities: Concordance and Divergence between Healthcare Providers and Expert Consensus Recommendations

Matthew Frigault, MD MSc, Megan Cartwright, PhD, Krista Marcello, BA, Timothy A Quill, PhD, Daniel J. DeAngelo, MD PhD, Ilene Galinsky, Shilpa Paul, PharmD, Jae H. Park, MD

Blood (2019) 134 (Supplement_1): 2199.

https://doi.org/10.1182/blood-2019-131533

Published: 2019

Journal Articles

Evolution in Practice Patterns and Differences Among Experts and Community Healthcare Providers in the Treatment of Patients with Chronic Lymphocytic Leukemia

Bing-E Xu, PhD, Kristen M Rosenthal, PhD, Krista Marcello, BA, Farrukh T. Awan, MD, Steven Coutre, MD, Nicole Lamanna, MD, Jeff P. Sharman, MD, Timothy A Quill, PhD, Kevin L Obholz, PhD, Andrew D. Zelenetz, MD PhD

Blood (2019) 134 (Supplement_1): 4724.

https://doi.org/10.1182/blood-2019-129266

Published: 2019

Journal Articles

Consensus and Divergence in Practice Patterns Among Experts and Community Healthcare Providers for the Treatment of Patients with Mantle Cell Lymphoma

Kristen M Rosenthal, PhD, Stephen M Ansell, MD PhD, John P. Leonard, MD, Julie M Vose, MDMBA, Michael L. Wang, MD, Timothy A Quill, PhD, Kevin L Obholz, PhD, Christopher R. Flowers, MD MS

Blood (2019) 134 (Supplement_1): 410.

https://doi.org/10.1182/blood-2019-124519

Published: 2019

Journal Articles

Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma

Rachael M Andrie, John M Burke, MD, Christopher R. Flowers, MD MS, Nathan H Fowler, MD, Jeff P. Sharman, MD, Timothy A Quill, PhD, Kevin L Obholz, PhD, Ian W. Flinn, MD PhD

Blood (2019) 134 (Supplement_1): 414.

https://doi.org/10.1182/blood-2019-128988

Published: 2019

Journal Articles

Refining Blood Products Utilization: Every One (unit) Matters

Khaled Deeb, PhD MBA, MD, Chen Zhang, MD, Stanislav Ivanov, MD MPH, Eric Szu, MD, Louis Lit, MD

Blood (2019) 134 (Supplement_1): 4985.

https://doi.org/10.1182/blood-2019-121339

Published: 2019

Journal Articles

Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease

Anna M Hood, PhD, Yolanda Johnson, MLS, Cara Nwankwo, BA, Lisa M Shook, MA, Aimee K Hildenbrand, PhD, Allison A. King, MD MPH, PhD, Kim Smith-Whitley, MD, Sherif M. Badawy, MD, Alexis A Thompson, MD MPH, Susan E Creary, MD, Connie M. Piccone, MD, Lynne D. Neumayr, Jean L. Raphael, MD MPH, Amber M Yates, MD, Sohail Rana, MD, Steven K Reader, PhD, Emily Riehm Meier, MD MSHS, Amy Sobota, MD MPH, Lori E. Crosby, PhD

Blood (2019) 134 (Supplement_1): 4713.

https://doi.org/10.1182/blood-2019-124835

Published: 2019

Journal Articles

Ex Vivo Drug Response Profiling Defines Novel Drug Sensitivity Patterns for Predicting Clinical Therapeutic Responses in Myeloid Neoplasms

Alexey Aleshin, MDMBA, Marianne A Santaguida, PhD, Michael A Spinner, MD, Jeffrey N Sanders, A Scott Patterson, Christos Gekas, PhD, Steven Schaffert, PhD, Peter L Greenberg, MD

Blood (2018) 132 (Supplement 1): 4356.

https://doi.org/10.1182/blood-2018-99-120146

Published: 2018

Journal Articles

Evolving Areas of Consensus and Disagreement Among Experts in Treatment of Patients with Multiple Myeloma (MM)

Kristen M Rosenthal, PhD, Irene M. Ghobrial, MD, Carol Ann Huff, MD, Sagar Lonial, MD, Noopur Raje, MD, Kevin L Obholz, PhD, Shaji K. Kumar, MD

Blood (2018) 132 (Supplement 1): 5664.

https://doi.org/10.1182/blood-2018-99-118941

Published: 2018

Journal Articles

Evolving Treatment Patterns of Healthcare Providers (HCPs) and Multiple Myeloma (MM) Experts from 2013-2017: Analysis of an Annually Updated Online Treatment Decision Tool

Kristen M Rosenthal, PhD, Carol Ann Huff, MD, Shaji K Kumar, MD, Suzanne Lentzsch, MD PhD, Sagar Lonial, MD, Kevin L Obholz, PhD, Terrence F. Fagan, Timothy A Quill, PhD, Kenneth C Anderson, MD

Blood (2017) 130 (Supplement 1): 3393.

https://doi.org/10.1182/blood.V130.Suppl_1.3393.3393

Published: 2017

Journal Articles

Analysis of Healthcare Provider Practice Patterns from Individual Patient Cases Entered into an Online Treatment Decision Tool for Chronic Lymphocytic Leukemia (CLL)

Kristen M Rosenthal, PhD, Farrukh T. Awan, MD MS, Steven Coutre, MD, Jeffrey A. Jones, MD MPH, MBA, Jeffrey P. Sharman, MD, Kevin L Obholz, PhD, Andrew D. Zelenetz, MD PhD

Blood (2017) 130 (Supplement 1): 5614.

https://doi.org/10.1182/blood.V130.Suppl_1.5614.5614

Published: 2017

Journal Articles

Adult Hemophagocytic Lymphohistiocytosis-a Quality Improvement Initiative

Samuel A. Merrill, MD PhD, Rakhi P. Naik, MD, Evan M Braunstein, MDPhD, Michael B. Streiff, Satish Shanbhag, MD, Sophie Lanzkron, MD, Alison R. Moliterno, MD, Robert A. Brodsky, MD

Blood (2017) 130 (Supplement 1): 677.

https://doi.org/10.1182/blood.V130.Suppl_1.677.221

Published: 2017

Journal Articles

Variance between Experts and Oncology Healthcare Providers in Managing Polycythemia Vera and Myelofibrosis: Analysis of an Online Treatment Decision Support Tool

Ryan P Topping, PhD, Michael W. Deininger, MD PhD, John Mascarenhas, MD, Ruben A Mesa, MD, Brady Lee Stein, MD, Kevin L Obholz, PhD, Jason J Everly, PharmD, Srdan Verstovsek, MD PhD

Blood (2017) 130 (Supplement 1): 2106.

https://doi.org/10.1182/blood.V130.Suppl_1.2106.2106

Published: 2017

Journal Articles

Utilizing Digital Pathology Informatics Algorithms for Diffuse Large B-Cell Lymphoma Subtyping

Jordan S. Goldstein, BS, Sanghoon Lee, Jacob Jordan, David L. Jaye, MD, Christopher Flowers, MD, Lee Cooper, PhD

Blood (2017) 130 (Supplement 1): 4147.

https://doi.org/10.1182/blood.V130.Suppl_1.4147.4147

Published: 2017

Journal Articles

Shared Decision Making or Physician Advocate for a Particular Treatment Option: A Spectrum of Approaches to Decision Making about Disease Modifying Therapies in Sickle Cell Disease

Nitya Bakshi, MBBS, MS, Cynthia Sinha, PhD, Diana Ross, MSN, RN, Kirshma Khemani, MD, George Loewenstein, PhD, Lakshmanan Krishnamurti, MD

Blood (2016) 128 (22): 4757.

https://doi.org/10.1182/blood.V128.22.4757.4757

Published: 2016

Journal Articles

Prediction of Allogeneic Stem Cell Transplantation Mortality in Patients with Acute Leukemia (AL) Using the AL- European Society for Blood and Marrow Transplantation (EBMT) Risk Score in the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO) Data Set: A Study on Behalf of the AL Working Party (ALWP) of the EBMT and GITMO

Roni Shouval, MD, Francesca Bonifazi, MD, Joshua Fein, Cristina Boschini, BSc, Elena Oldani, BiolSc, Myriam Labopin, Roberto Raimondi, MD, Osamah Dabash, MD, Ron Unger, PhD, Mohamad Mohty, MD PhD, Alessandro Rambaldi, MD, Arnon Nagler

Blood (2016) 128 (22): 989.

https://doi.org/10.1182/blood.V128.22.989.989

Published: 2016

Journal Articles

Analysis of an Online Decision Support Tool for Chronic Lymphocytic Leukemia: Disparities in Treatment Selection Between Experts and Community Practitioners

Kristen M Rosenthal, PhD, Farrukh T. Awan, Jacqueline C. Barrientos, MD, Steven E. Coutre, MD, Kevin L Obholz, PhD, Andrew D. Zelenetz, MD PhD

Blood (2016) 128 (22): 5958.

https://doi.org/10.1182/blood.V128.22.5958.5958

Published: 2016

Journal Articles

Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus (CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection

Ifigeneia Tzannou, MD, Kathryn S. Leung, Caridad Martinez, MD, Swati Naik, MD, Stephen Gottschalk, MD, Adrian P. Gee, PhD, Bambi Grilley, Ayumi Watanabe, Ann M. Leen, PhD, Sunitha Kakarla, PhD, Bilal Omer, MD

Blood (2016) 128 (22): 388.

https://doi.org/10.1182/blood.V128.22.388.388

Published: 2016

Journal Articles

Areas of Consensus and Differences Among a Panel of Experts on the Optimal Use of Newly Approved Agents to Treat Multiple Myeloma (MM): Results from an Annually Updated Online Decision Support Tool

Timothy A Quill, PhD, Kristen M Rosenthal, PhD, Shaji Kumar, MD, Suzanne Lentzsch, MD PhD, Sagar Lonial, MD FACP, G. David Roodman, MD PhD, Kevin L Obholz, PhD, Kenneth C. Anderson, MD

Blood (2016) 128 (22): 2379.

https://doi.org/10.1182/blood.V128.22.2379.2379

Published: 2016

NARROW

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

Knowledge Transfer between Artificial Neural Networks for Different Multicolor Flow Cytometry Protocols Improves Classification Performance for Rare B-Cell Neoplasm Subtypes

Management of CAR T-Cell Toxicities: Concordance and Divergence between Healthcare Providers and Expert Consensus Recommendations

Evolution in Practice Patterns and Differences Among Experts and Community Healthcare Providers in the Treatment of Patients with Chronic Lymphocytic Leukemia

Consensus and Divergence in Practice Patterns Among Experts and Community Healthcare Providers for the Treatment of Patients with Mantle Cell Lymphoma

Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma

Refining Blood Products Utilization: Every One (unit) Matters

Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease

Ex Vivo Drug Response Profiling Defines Novel Drug Sensitivity Patterns for Predicting Clinical Therapeutic Responses in Myeloid Neoplasms

Evolving Areas of Consensus and Disagreement Among Experts in Treatment of Patients with Multiple Myeloma (MM)

Evolving Treatment Patterns of Healthcare Providers (HCPs) and Multiple Myeloma (MM) Experts from 2013-2017: Analysis of an Annually Updated Online Treatment Decision Tool

Analysis of Healthcare Provider Practice Patterns from Individual Patient Cases Entered into an Online Treatment Decision Tool for Chronic Lymphocytic Leukemia (CLL)

Adult Hemophagocytic Lymphohistiocytosis-a Quality Improvement Initiative

Variance between Experts and Oncology Healthcare Providers in Managing Polycythemia Vera and Myelofibrosis: Analysis of an Online Treatment Decision Support Tool

Utilizing Digital Pathology Informatics Algorithms for Diffuse Large B-Cell Lymphoma Subtyping

Shared Decision Making or Physician Advocate for a Particular Treatment Option: A Spectrum of Approaches to Decision Making about Disease Modifying Therapies in Sickle Cell Disease

Analysis of an Online Decision Support Tool for Chronic Lymphocytic Leukemia: Disparities in Treatment Selection Between Experts and Community Practitioners

Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus (CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection

Areas of Consensus and Differences Among a Panel of Experts on the Optimal Use of Newly Approved Agents to Treat Multiple Myeloma (MM): Results from an Annually Updated Online Decision Support Tool

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only